EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Effect of Sargassum fusiforme and Fucus vesiculosus on Continuous Glucose Levels in Overweight Patients with Type 2 Diabetes Mellitus: A Feasibility Randomized, Double-Blind, Placebo-Controlled Trial

Karlijn A M Geurts iD, Sjoerd Meijer, Jeanine E Roeters van Lennep, Xi Wang iD, Behiye Özcan, Gardi Voortman, Hongbing Liu, Manuel Castro Cabezas, Kirsten A Berk iD, Monique T Mulder

Nutrients · 12.06.2024 · 16 (12) · 1837

DOI: 10.3390/nu16121837 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 12.06.2024. Verfasst von Karlijn A M Geurts und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sargassum, Blood Glucose, Fucus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Holland, Zhejiang Yukang Food Co., Ltd., Seaweed Harvest Holland/St. Zeeschelp..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brown seaweed is promising for the treatment of type 2 diabetes mellitus (T2DM). Its bioactive constituents can positively affect plasma glucose homeostasis in healthy humans. We investigated the effect of the brown seaweeds Sargassum (S.) fusiforme and Fucus (F.) vesiculosus in their natural form on glucose regulation in patients with T2DM.

Methods

We conducted a randomized, double-blind, placebo-controlled pilot trial. Thirty-six participants with T2DM received, on a daily basis, either 5 g of dried S. fusiforme, 5 g of dried F. vesiculosus, or 0.5 g of dried Porphyra (control) for 5 weeks, alongside regular treatment. The primary outcome was the between-group difference in the change in weekly average blood glucose levels (continuous glucose monitoring). The secondary outcomes were the changes in anthropometrics, plasma lipid levels, and dietary intake. The data were analyzed using a linear mixed-effects model.

Results

The change in weekly average glucose levels was 8.2 ± 2.1 to 9.0 ± 0.7 mmol/L (p = 0.2) in the S. fusiforme group (n = 12) and 10.1 ± 3.3 to 9.2 ± 0.7 mmol/L (p = 0.9) in the F. vesiculosus group (n = 10). The between-group difference was non-significant. Similarly, no between-group differences were observed for the changes in the secondary outcomes.

Discussion

A daily intake of 5 g of fresh, dried S. fusiforme or F. vesiculosus alongside regular treatment had no differential effect on weekly average blood glucose levels in T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2SargassumBlood GlucoseFucusHumansDouble-Blind MethodMaleFemaleMiddle AgedPilot ProjectsOverweightFeasibility StudiesAgedAdultSeaweedHypoglycemic AgentsEdible Seaweeds

Stichwörter der Autor:innen

Fucus vesiculosusSargassum fusiformebody compositioncardiovascular risk factorsseaweedtype 2 diabetes mellitus

Substanzen

Blood GlucoseHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
  • Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266100, China.
  • Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Schiedamse Vest 180, 3011 BH Rotterdam, The Netherlands.

ORCID-Profile: Karlijn A M Geurts, Xi Wang, Kirsten A Berk

Förderung

  • Health Holland
  • Zhejiang Yukang Food Co., Ltd.
  • Seaweed Harvest Holland/St. Zeeschelp.

Zitieren

APA

Geurts, K. A. M., Meijer, S., Roeters van Lennep, J. E., Wang, X., Özcan, B., Voortman, G., Liu, H., Castro Cabezas, M., Berk, K. A., & Mulder, M. T. (2024). The Effect of Sargassum fusiforme and Fucus vesiculosus on Continuous Glucose Levels in Overweight Patients with Type 2 Diabetes Mellitus: A Feasibility Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 16(12), 1837. https://doi.org/10.3390/nu16121837

Vancouver

Geurts KAM, Meijer S, Roeters van Lennep JE, Wang X, Özcan B, Voortman G, et al. The Effect of Sargassum fusiforme and Fucus vesiculosus on Continuous Glucose Levels in Overweight Patients with Type 2 Diabetes Mellitus: A Feasibility Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2024;16(12):1837. doi:10.3390/nu16121837

BibTeX
@article{Geurts2024,
  author = {Geurts, Karlijn A M and Meijer, Sjoerd and Roeters van Lennep, Jeanine E and Wang, Xi and Özcan, Behiye and Voortman, Gardi and Liu, Hongbing and Castro Cabezas, Manuel and Berk, Kirsten A and Mulder, Monique T},
  title = {The Effect of Sargassum fusiforme and Fucus vesiculosus on Continuous Glucose Levels in Overweight Patients with Type 2 Diabetes Mellitus: A Feasibility Randomized, Double-Blind, Placebo-Controlled Trial},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {12},
  pages = {1837},
  doi = {10.3390/nu16121837}
}
Kostenlos starten →